alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit
32.1
   CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER
 AND
PRINCIPAL FINANCIAL OFFICER
 PURSUANT
TO 18 U.S.C. SECTION 1350
   In
connection with the accompanying Quarterly Report on Form 10-Q of
Mortgagebrokers.com Holdings, Inc. for the Quarter Ending September 30,
2008, I, Alex Haditaghi, Principal Executive Officer and Principal Financial
Officer of Mortgagebrokers.com Holdings, Inc. hereby certify pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, to the best of my knowledge and belief, that:
  1. Such
Quarterly Report on Form 10-Q for the period ending September 30, 2008,
fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
  2. The
information contained in such Quarterly Report on Form 10-Q for the period
ended September 30, 2008, fairly represents in all material respects, the
financial condition and results of operations of Mortgagebrokers.com Holdings,
Inc.
   Dated: 
November 18, 2008
   MORTGAGEBROKERS.COM
HOLDINGS, INC.
   By:
              /s/
      Alex HaditaghiAlex
      Haditaghi
                Chief
      Executive Officer,
                Chief
      Financial Officer and
                Principal
      Accounting Officer
#### Oscar Fried, Plaintiff, v. New York, New Haven and Hartford Railroad Company, Defendant.

Motion denied, without costs. Present — Jenks, P. J., Thomas, Carr, Rich and Putnam, JJ.
[Federal Register Volume 69, Number 217 (Wednesday, November 10, 2004)]
[Notices]
[Page 65229]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-25104]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to 21 CFR 1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 28, 2004, Guilford 
Pharmaceuticals, Inc., 6611 Tributary Street, Baltimore, Maryland 
21224, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of Cocaine 
(9041), a basic class of controlled substance in Schedule II.
    The company plans to manufacture a cocaine derivative to be used as 
an intermediate for the production of Dopascan Injection. Cocaine 
derivatives are a Schedule II controlled substance in the cocaine basic 
class.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
Office of Liaison and Policy (ODLR) and must be filed no later than 
January 10, 2005.

    Dated: November 1, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-25104 Filed 11-9-04; 8:45 am]
BILLING CODE 4410-09-P
ESTABLISHING AN OFFICE IN RUSSIA

----
NRC ASSIGNS NEW INSPECTOR TO GINNA NUCLEAR PLANT

Nuclear Regulatory Commission officials in King of Prussia, Pa., 

have selected Douglas Dodson as the new resident inspector at the R.E. 

Ginna nuclear power plant in Ontario, N.Y. He joins Senior Resident 

Inspector Gordon Hunegs at Ginna, which is operated by Constellation 

Energy.

Dodson graduated from the University of Missouri–Columbia with a 

bachelor’s of science degree in mechanical and aerospace engineering and a 

bachelor of arts in religious studies. He joined the agency in 2007. He is a graduate of the NRC’s 

Nuclear Safety Professional Development Program, a two-year training program that provides 

specialized training in nuclear safety and a broad perspective of NRC regulatory activities. He 

has also completed a rigorous NRC inspector qualification program and is also a qualified 

technical reviewer. Most recently, Dodson worked as project engineer in the Region I office. 

“Doug Dodson has the training and commitment to safety that will help the NRC carry

out its mission of protecting people and the environment, and ensure the safe operation of 

Ginna,” said NRC Region I Administrator Bill Dean. 

Each U.S. commercial nuclear power plant site has at least two NRC Resident Inspectors.

They serve as the agency's eyes and ears at the facility, conducting regular inspections, 

monitoring significant work projects, and interacting with plant workers and the public. 

Inspectors can serve for up to 7 years at any one site.

The Ginna resident inspectors can be reached at 315-524-6935.

#

News releases are available through a free listserv subscription or by clicking on the EMAIL UPDATES link on the 

NRC homepage (www.nrc.gov). E-mail notifications are sent to subscribers when news releases are posted to NRC's 

website. For the latest news, follow the NRC on www.twitter.com/NRCgov.

NRC NEWS

U.S. NUCLEAR REGULATORY COMMISSION

Office of Public Affairs, Region I 

475 Allendale Road, King of Prussia, Pa. 19406

E-mail: opa1@nrc.gov 

Site: www.nrc.gov

Blog: http://public-blog.nrc-gateway.gov

No. I-11-035

Contact: Diane Screnci (610) 337-5330

 Neil Sheehan (610) 337-5331

September 13, 2011

Email: opa1.resource@nrc.gov
[Federal Register Volume 69, Number 221 (Wednesday, November 17, 2004)]
[Notices]
[Page 67359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-25488]


=======================================================================
-----------------------------------------------------------------------

FEDERAL MARITIME COMMISSION


Notice of Agreements Filed

    The Commission hereby gives notice of the filing of the following 
agreements under the Shipping Act of 1984. Interested parties may 
obtain copies of agreements by contacting the Commission's Office of 
Agreements at 202-523-5793 or via e-mail at <a href="/cdn-cgi/l/email-protection#7c080e1d18191d121d10050f150f3c1a111f521b130a"><span class="__cf_email__" data-cfemail="e39791828786828d828f9a908a90a3858e80cd848c95">[email protected]</span></a>. 
Interested parties may submit comments on an agreement to the 
Secretary, Federal Maritime Commission, Washington, DC 20573, within 10 
days of the date this notice appears in the Federal Register.
    Agreement No.: 011756-002.
    Title: New World Alliance/Evergreen Slot Exchange Agreement.
    Parties: APL Co. Pte. Ltd. and American President Lines, Ltd.; 
Mitsui O.S.K. Lines, Ltd.; Hyundai Merchant Marine Co., Ltd.; and 
Evergreen Marine Corp. (Taiwan) Ltd.
    Filing Party: Eliot J. Halperin, Esq.; Manelli, Denison & Selter 
PLLC; 2000 M Street, NW.; 7th Floor; Washington, DC 20036.
    Synopsis: The modification would permit greater flexibility in 
allocating space under the agreement. The parties request expedited 
review.

    Dated: November 12, 2004.

    By Order of the Federal Maritime Commission.
Karen V. Gregory,
Assistant Secretary.
[FR Doc. 04-25488 Filed 11-16-04; 8:45 am]
BILLING CODE 6730-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.1    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002   In connection with the Quarterly Report of AIDA Pharmaceuticals, Inc. a Nevada corporation (the Company), on Form 10-QSB for the annual period ending March 31, 2007 as filed with the Securities and Exchange Commission (the Report), I, Biao Jin, Chief Executive Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350), that to my knowledge:  (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.    /s/ Biao Jin Biao Jin Chief Executive Officer Date: May 14, 2007
§ 18.14 When an application may be filed. ( a ) An application may be filed whenever the applicant has prevailed in the proceeding or in a significant and discrete substantive portion of the proceeding, but in no case later than 30 days after the Department's final disposition of the proceeding.
( b ) For purposes of this rule, final disposition means the date on which a decision or order disposing of the merits of the proceeding or any other complete resolution of the proceeding, such as a settlement or voluntary dismissal, becomes final and unappealable, both within the agency and to the courts.
( c ) If review or reconsideration is sought or taken of a decision as to which an applicant believes it has prevailed, proceedings for the award of fees shall be stayed pending final disposition of the underlying controversy. When the United States appeals the underlying merits of an adversary adjudication to a court, no decision on an application for fees and other expenses in connection with that adversary adjudication shall be made until a final and unreviewable decision is rendered by the court on the appeal or until the underlying merits of the case have been finally determined pursuant to the appeal.
[47 FR 13510, Mar. 31, 1982, as amended at 53 FR 6799, Mar. 3, 1988]
§ 734.412 Participation in elections; prohibitions. An employee covered under this subpart may not: ( a ) Be a candidate for partisan political office;
( b ) Act as recorder, watcher, challenger, or similar officer at polling places in concert with a political party, partisan political group, or a candidate for partisan political office;
( c ) Drive voters to polling places in concert with a political party, partisan political group, or a candidate for partisan political office.
[59 FR 48769, Sept. 23, 1994, as amended at 61 FR 35102, July 5, 1996]
[Federal Register Volume 69, Number 219 (Monday, November 15, 2004)]
[Notices]
[Page 65612]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-25273]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel, Women's Reproductive Health 
Research Career Development Program.
    Date: November 22, 2004.
    Time: 9:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Select Bethesda, 8120 Wisconsin Avenue, 
Bethesda, MD 20814.
    Contact Person: Gopal M. Bhatnagar, PhD, Scientific Review 
Administrator, National Institute of Child Health and Human 
Development, National Institutes of Health, 6100 Bldg Rm 5B01, 
Rockville, MD 20852, (301) 435-6889, <a href="/cdn-cgi/l/email-protection#ed8f858c99838c8a8aad808c8481c3838485c38a829b"><span class="__cf_email__" data-cfemail="23414b42574d424444634e424a4f0d4d4a4b0d444c55">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: November 5, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-25273 Filed 11-12-04; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92-463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—DP19-005, Research to Enhance the US Vision and Eye Health Surveillance System.                    

*Dates:*                         March 28, 2019.                    

*Times:*                         11:00 a.m.-6:00 p.m., EDT.                    

*Place:*                         Teleconference.                    

*Agenda:*                         To review and evaluate grant applications.                    

*For Further Information Contact:*                         Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488-6511,                         *kva5@cdc.gov.*

                        The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign                         **Federal Register**                         notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.                    

Sherri Berger,

Chief Operating Officer, Centers for Disease Control and Prevention.

[FR Doc. 2019-00275 Filed 1-29-19; 8:45 am]

 BILLING CODE 4163-18-P
#### Select Theatres Corporation, Suing on Behalf of Itself and All Other Stockholders of Shubert Music Publishing Corporation, v. Harms, Inc., et al.

Motion for leave to appeal to the Court of Appeals denied, with $10 costs. Present — Grlennon, J.P., Dore, Cohn, Callahan and Shientag, JJ. [See *ante,*p. 505.]
§ 838.504 OPM computation of formulas. ( a ) A court order directed at a refund of employee contributions is not a court order acceptable for processing unless the court order provides sufficient instructions and information so that OPM can compute the amount of the former spouse's share of the refund of employee contributions using only the express language of the court order, subparts A, D, and F of this part, and information from normal OPM files.
( b ) To provide sufficient instructions and information that OPM can compute the amount of the former spouse's share of the refund of employee contributions as required by paragraph (a) of this section requires that the court order state the former spouse's share as— ( 1 ) A fixed amount;
( 2 ) A percentage or a fraction of the refund of employee contributions; or
( 3 ) A formula that does not contain any variables whose values are not readily ascertainable from the face of the court order or normal OPM files.
( c ) A court order directed at a refund of employee contributions is not a court order acceptable for processing if OPM would have to examine a State statute or court decision (on a different case) to understand, establish, or evaluate the formula for computing the former spouse's share of the refund of employee contributions.
[Federal Register Volume 84, Number 21 (Thursday, January 31, 2019)]
[Notices]
[Page 786]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00363]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Molecular and Cellular Endocrinology Study Section.
    Date: February 7, 2019.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: San Diego Marriott Mission Valley, 8757 Rio San Diego 
Drive, San Diego, CA 92108.
    Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review 
Officer, EMNR IRG, Center for Scientific Review, National Institutes 
of Health, 6701 Rockledge Drive, Room 6182, MSC 7892, Bethesda, MD 
20892, 301 435-2514, <a href="/cdn-cgi/l/email-protection#2f5d46594a5d4e5c4a6f4c5c5d0141464701484059"><span class="__cf_email__" data-cfemail="7d0f140b180f1c0e183d1e0e0f53131415531a120b">[email protected]</span></a>.

    This meeting notice is being published less than 15 days in 
advance of the meeting due to the partial Government shutdown of 
December 2018.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: January 24, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-00363 Filed 1-30-19; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Fourth Court of Appeals

San Antonio, Texas

June 28, 2019

No. 04-19-00428-CR

The STATE of Texas,

Appellant

v.

Raymond SOTO,

Appellee

From the 226th Judicial District Court, Bexar County, Texas

Trial Court No. 2018CR9019

The Honorable Velia J. Meza, Judge Presiding

O R D E R

In its notices of appeal, the State requested a stay pursuant to article 44.01(e) of the Texas 

Code of Criminal Procedure. The request is GRANTED, and all proceedings in the underlying 

causes are STAYED pending final disposition of this appeal. TEX. CODE CRIM. PROC. art. 

44.01(e).

_________________________________

Sandee Bryan Marion, Chief Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 28th day of June, 2019.

___________________________________

KEITH E. HOTTLE,

Clerk of Court
#### In the Matter of the Voluntary Dissolution of City Commercial Corp. Kenneth Carroad et al., Respondents; Leonard I. Shankman, Individually and as Executor of Samuel B. Shankman, Deceased, Appellant.

Order unanimously affirmed, with $20 costs and disbursements to petitioners-respondents. No opinion. Present — Peck, P. J., Glennon, Cohn, Callahan and Breitel, JJ. [See *post,*p. 759.]
No: IV-08-018 May 13, 2008 

CONTACT: Victor Dricks E-mail: opa4@nrc.gov 

 Phone: 817-860-8128 

NRC TO DISCUSS 2007 PERFORMANCE ASSESSMENT 

FOR WOLF CREEK NUCLEAR PLANT 

The Nuclear Regulatory Commission staff will meet in Burlington, Kan., on May 15, 

with representatives of Wolf Creek Nuclear Operating Corporation, to discuss the agency's 

assessment of safety performance for last year at the Wolf Creek nuclear plant. 

The meeting, which will be open to the public, is scheduled to begin at 6 p.m. at the 

Coffey County Library, Burlington Branch, 410 Juniatta Street in Burlington. 

In addition to the performance assessment, the NRC staff will be available to answer 

questions from the public on the safety performance of Wolf Creek, as well as the NRC's role in 

ensuring safe plant operation. 

"The NRC continually reviews the performance of Wolf Creek and the nation's other 

commercial nuclear power facilities," NRC Region IV Administrator Elmo E. Collins said. "This 

meeting will provide an opportunity for a discussion of our annual assessment of safety 

performance with the company and with local officials and residents who live near the plant." 

A letter sent from the NRC Region IV office to plant officials addresses the performance 

of the plant during 2007 and will serve as the basis for the meeting discussion. It is available on 

the NRC web site at: 

http://www.nrc.gov/NRR/OVERSIGHT/ASSESS/LETTERS/wc_2007q4.pdf. 

The NRC utilizes color-coded inspection findings and performance indicators to assess 

nuclear power plant performance. The colors start with "green" and then increase to "white," 

"yellow" or "red," commensurate with the safety significance of the issues involved. 

The NRC said the Wolf Creek plant operated safely during 2007 and will receive regular, 

or baseline inspections during 2008. 

Routine inspections are performed by two NRC Resident Inspectors assigned to the plant 

and by inspection specialists from the Region IV Office in Arlington, Texas. 

NRC NEWS

U.S. NUCLEAR REGULATORY COMMISSION 

Office of Public Affairs, Region IV 

611 Ryan Plaza Drive, Suite 400, Arlington TX 76011 

www.nrc.gov
Current performance information for Wolf Creek is available on the NRC web site at: 

http://www.nrc.gov/NRR/OVERSIGHT/ASSESS/WC/wc_chart.html. 

### 

 News releases are available through a free listserv subscription at the following Web address: 

http://www.nrc.gov/public-involve/listserver.html. The NRC homepage at www.nrc.gov also offers a SUBSCRIBE 

link. E-mail notifications are sent to subscribers when news releases are posted to NRC's Web site.